Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ANALYST INTERVIEW: BIOTECHNOLOGY & VENTURE CAPITAL: CARL GORDON - ORBIMED ADVISORS LLC.


(PAJ900) BIOTECHNOLOGY & VENTURE CAPITAL: CARL GORDON - ORBIMED ADVISORS LLC. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 5/8/02. Tickers featured: ABGX, AFFX, AMGN, DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
, DNDN, IDPH IDPH Illinois Department of Public Health
IDPH Iowa Department of Public Health
, ISTA, MEDI MEDI Marine Environmental Data Information Referral System , MEDX, MRVT, PCOP, VPHM, ZGEN. Complete text approximately 3000 words. Document # PAJ900.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:ANALYST INTERVIEW: BIOTECHNOLOGY & VENTURE CAPITAL: CARL GORDON - ORBIMED ADVISORS LLC.(Brief Article)(Industry Overview)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:108
Previous Article:ANALYST INTERVIEW: BIOTECHNOLOGY & BETTER COMMUNICATION: DONALD JOHNSTON - AMERICAN HEALTH CONSULTANTS.
Next Article:CEO INTERVIEW: ROBERT VAN NOSTRAND - OSI PHARMACEUTICALS INC (OSIP).
Topics:



Related Articles
ANALYST INTERVIEW: THE BIOTECHNOLOGY REVOLUTION: AN OVERVIEW: CARL FELDBAUM - BIOTECHNOLOGY INDUSTRY ORGANIZATION.
City announces fund investment.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles